Kvaløysletta, Norway

John Sigurd Svendsen

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Tromsø, NO (2008 - 2012)
  • Kvaloysletta, NO (2013 - 2019)
  • Kvaløysletta, NO (2007 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: John Sigurd Svendsen: Innovator in Antimicrobial and Neurodegenerative Disorder Treatments

Introduction

John Sigurd Svendsen is a notable inventor based in Kvaløysletta, Norway. He has made significant contributions to the fields of antimicrobial compounds and treatments for neurodegenerative disorders. With a total of 17 patents to his name, Svendsen's work has the potential to impact various therapeutic areas.

Latest Patents

One of Svendsen's latest patents involves antimicrobial compounds. This invention relates to a compound of formula (I) AA-AA-AA-R—R(I), where two of the AA moieties are cationic amino acids and one is an amino acid with a lipophilic R group. The R group consists of 14-27 non-hydrogen atoms, and the invention further explores formulations containing these compounds for therapeutic uses, particularly as antimicrobial, anti-tumor, or anti-biofilm agents. Another significant patent is for benzothiazole derivatives as DYRK1 inhibitors. This invention focuses on compounds that inhibit DYRK1A and/or DYRK1B, with applications in treating neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, as well as metabolic disorders and cancer.

Career Highlights

Throughout his career, Svendsen has worked with various companies, including Lytix Biopharma AS and Peptide Patents AS. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Svendsen has collaborated with notable colleagues such as Øystein Rekdal and Wenche Stensen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John Sigurd Svendsen's contributions to the fields of antimicrobial compounds and neurodegenerative disorder treatments highlight his innovative spirit and dedication to improving health outcomes. His extensive patent portfolio reflects his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…